Acotec Scientific Holdings Limited (7W3) Financial Statements
Acotec Scientific Holdings Limited Financial Overview
Acotec Scientific Holdings Limited's market cap is currently $186.07M. The company's EPS TTM is $-0.16; its P/E ratio is -27.72; Acotec Scientific Holdings Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 644.63M | $ 533.99M | $ 473.85M | $ 395.55M | $ 303.81M |
| Gross Profit | $ 476.31M | $ 402.72M | $ 377.42M | $ 336.35M | $ 265.94M |
| Operating Income | $ 133.15M | $ 64.01M | $ 25.01M | $ 72.08M | $ 63.42M |
| EBITDA | $ 159.45M | $ 112.48M | $ 70.54M | $ 91.17M | $ -51.02M |
| Net Income | $ 119.18M | $ 52.28M | $ 14.49M | $ 70.14M | $ -79.08M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 948.37M | $ 809.57M | $ 879.21M | $ 986.46M | $ 1.14B |
| Total Assets | $ 1.87B | $ 1.66B | $ 1.61B | $ 1.41B | $ 1.31B |
| Total Debt | $ 244.49M | $ 202.92M | $ 234.00M | $ 47.78M | $ 24.57M |
| Net Debt | $ -155.50M | $ -548.47M | $ -403.63M | $ -938.67M | $ -1.11B |
| Total Liabilities | $ 392.18M | $ 312.76M | $ 314.53M | $ 134.46M | $ 100.17M |
| Stockholders' Equity | $ 1.48B | $ 1.35B | $ 1.30B | $ 1.28B | $ 1.21B |
| Cash Flow | |||||
| Free Cash Flow | $ 145.46M | $ 5.31M | $ -92.54M | $ -115.45M | $ -31.72M |
| Operating Cash Flow | $ 167.32M | $ 102.79M | $ -12.88M | $ -68.75M | $ -10.48M |
| Investing Cash Flow | $ -527.16M | $ 45.02M | $ -319.22M | $ -49.17M | $ -20.48M |
| Financing Cash Flow | $ 24.79M | $ -35.24M | $ -23.21M | $ -32.87M | $ 1.02B |
Currency in CNY